Inventor · disambiguated record
Mark Benton
Also filed as: BENTON MARK
1 granted patent·3 pending applications·1 citations·filing 2020–2021
17Inventor score
Technology areasA61K
Files withCRISPR THERAPEUTICS AG4
Top patents by PatentIndex Score
4 records- 0184US11389481B2Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19CRISPR THERAPEUTICS AG·Filed 2021·Granted Jul 19, 2022·1 cites·20 claims
- 0256US2022249558A1Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19CRISPR THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 0354US2022118019A1Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19CRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0452US2022023344A1Allogeneic cell therapy of acute lymphoblastic leukemia using genetically engineered t cells targeting cd19CRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Benton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →